دوره 10، شماره 2 - ( 4-1401 )                   جلد 10 شماره 2 صفحات 4-4 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tabrizi M, Hoseini Nouri S A, Zarkesh M, Hassanzadeh Rad A, Hashemi Dehkordi E, Dalili S. Management of growth in pediatric chronic renal failure: A narrative review. J. Pediatr. Rev. 2022; 10 (2) :4-4
URL: http://jpr.mazums.ac.ir/article-1-445-fa.html
Management of growth in pediatric chronic renal failure: A narrative review. Journal of Pediatrics Review. 1401; 10 (2) :4-4

URL: http://jpr.mazums.ac.ir/article-1-445-fa.html


چکیده:   (535 مشاهده)
Context:Growth impairment is a common problem in chronic kidney disease (CKD) children. Approximately 40 % of children with CKD have a reduced final height. Growth impairment affects school attendance, duration of hospitalization, adult height, and even risk of death. Various studies have shown that patients with moderate to severe growth failure have higher mortality rates (three folds) than those with normal growth. This narrative review aimed to define the management of growth in pediatric chronic renal failure.
Evidence acquisition: This study was conducted through a literature search with the keywords of chronic renal failure, kidney transplant, glomerular filtration rate (GFR) combined with growth, short stature, and growth hormone in PubMed, Scopus, ISI Web of Sciences, Cochrane, and Embase databases.
Results: Previous studies showed that growth impairment in children with CKD occurs due to diverse etiologies such as uremia, anemia, metabolic acidosis, etc. It becomes more prominent in GFR<75 ml/min/1.73 m2. GH therapy seems to be a safe and effective therapeutic modality consequent to the correction of associated metabolic disturbances. 
Conclusions: This study indicated that pretransplant GH therapy in children with CKD and its temporary discontinuation at kidney transplantation up to 1 year after transplantation leads to improved growth velocity. Therefore, it seems that considering GH therapy in children with CKD is mandatory.

 
     
نوع مطالعه: Narrative Review |
دریافت: 1400/9/17 | پذیرش: 1400/10/6 | انتشار: 1401/2/5

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Pediatrics Review می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2022 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb